外資系製薬　MSLの転職・求人情報 6281256

募集要項

募集背景: グローバルな研究開発型バイオ医薬品企業です。世界の最も複雑で深刻な疾患に対する先進的な治療薬を開発し市場に投入することで、長年にわたり培われた医薬品業界のリーダーとしての専門技術と能力をもとに、最先端のバイオテクノロジーに対するフォーカスと情熱を注ぎます。世界中で約28,000人の社員を擁し、170以上の国々において医薬品の販売を行います。

仕事内容: Major Responsibilities:
1. KOL management
• KOL selection (including future KOLs) based on influence toward healthcare professionals
• Cultivate and maintain relationships with KOLs prior to product launch
• Provide scientific information and have a discussion with KOLs
• Provide accurate TA knowledge and scientific message to KOLs (non-product)

2. Coordinate Investigator Initiated Study (IIS) following new SOP (Contract-Based IIS)
• Get information of IIS plan with products and may proceed further process.
• Support other departments in scientific point of view
• Provide scientific information

3. Internal medical training (e.g. MR, safety)
• Provide Medical Education program

4. Set up TA based scientific series meetings with external physicians (KOL, future KOL)
• Scientific series meeting in area level will be organized regularly

応募資格

必須: Essential Skills & Abilities/Education:
• Must have an undergraduate degree in science or pharmacology
• Masters in Science or PhD preferred
• Experience in Pharmaceutical industry in Clinical Development, Safety department or research experience more than 3 years
• Affluent and accurate senses about pharmaceutical market
• Drive for Results
• Strong human relationship with people outside (especially wholesalers and KOL)
• High reputation among people inside and outside
• Correct expression of view as to right or wrong of things
• Well balanced decision making
• Clear recognition/discipline of performance

フィットする人物像: Summary of Job Description:
1. Enhance products value scientifically
2. Regional KOL’s management with scientific communication
3. Implement publication strategy through IIS executions
4. Develop scientific projects in partnership with health care practitioners
5. Support regional training for sales team related science
6. Reinforce brand message through the dissemination of clinical data
7. Comprehensive coverage of medical congresses